UOC
BPMC
UBS O'Connor’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220M | Buy |
1,713,587
+1,698,722
| +11,428% | +$218M | 11.25% | 1 |
|
|
2025
Q1 | $1.32M | Sell |
14,865
-5,268
| -26% | -$466K | 0.04% | 151 |
|
|
2024
Q4 | $1.76M | Sell |
20,133
-2,120
| -10% | -$185K | 0.05% | 166 |
|
|
2024
Q3 | $2.06M | Buy |
22,253
+5,910
| +36% | +$547K | 0.05% | 163 |
|
|
2024
Q2 | $1.76M | Sell |
16,343
-1,657
| -9% | -$179K | 0.05% | 209 |
|
|
2024
Q1 | $1.71M | Buy |
18,000
+9,000
| +100% | +$854K | 0.05% | 205 |
|
|
2023
Q4 | $830K | Sell |
9,000
-39,984
| -82% | -$3.69M | 0.03% | 286 |
|
|
2023
Q3 | $2.46M | Buy |
48,984
+1,200
| +3% | +$60.3K | 0.04% | 206 |
|
|
2023
Q2 | $3.02M | Sell |
47,784
-1,449
| -3% | -$91.6K | 0.06% | 191 |
|
|
2023
Q1 | $2.21M | Buy |
+49,233
| New | +$2.21M | 0.05% | 297 |
|
|
2022
Q3 | – | Sell |
-20,390
| Closed | -$1.03M | – | 918 |
|
|
2022
Q2 | $1.03M | Buy |
+20,390
| New | +$1.03M | 0.01% | 746 |
|